Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
NEW YORK, March 25, 2016 -- Rosen Law Firm, a global investor rights law firm, announces it is continuing to investigate potential securities claims on behalf of purchasers of Herbalife Ltd. securities (NYSE:HLF) from August 6, 2015 through March 2, 2016 resulting from allegations that Herbalife may have issued materially misleading business information to the investing public.
On March 3, 2016, Herbalife announced that it misstated an important member growth metric 28 times over three earnings calls since last year. On this news, shares of Herbalife fell $3.96 per share or over 7% from its previous closing to close at $52.42 per share on March 3, 2016.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Herbalife investors. If you purchased shares of Herbalife from August 6, 2015 through March 2, 2016, please visit the firm’s website at http://rosenlegal.com/cases-269.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com
